exelon patch
novartis pharmaceuticals australia pty ltd - rivastigmine -
norspan
mundipharma pty ltd - buprenorphine -
hylo-forte - lubricant, eye
aft pharmaceuticals pty ltd - 44237 - lubricant, eye - drops to improve lubrication of the eye surface in eyes that are severely dry and irritated from external factors. they are supplied in a double walled dropper bottle with an airless pump that delivers one drop of product per actuation of the pump. to improve the lubrication of the eye in eyes that are experiencing severe or persistent dryness
interclene 165 bright red tin free antifouling
akzo nobel pty limited - cuprous oxide; diuron - paint - cuprous oxide mineral-copper active 525.0 g/l; diuron urea-substituted active 45.0 g/l - antifouling - boat - exterior (antifouling) - fouling - for antifouling on boats
exelon patch 10
novartis new zealand ltd - rivastigmine 18mg; ; - transdermal patch - 9.5 mg/24h - active: rivastigmine 18mg excipient: dimeticone dl-alpha tocopherol acrylic pressure sensitive adhesive silicone pressure sensitive adhesive backing film 10 cm square release liner 20.25 cm square poly(butyl methacrylate-co-methyl methacrylate) - treatment of patients with: · mild to moderately severe dementia of the alzheimer's type (also termed probable alzheimer's disease or alzheimer's disease) · severe dementia of the alzheimer's type.
exelon patch 15
novartis new zealand ltd - rivastigmine 27mg; ; - transdermal patch - 13.3 mg/24h - active: rivastigmine 27mg excipient: dimeticone dl-alpha tocopherol acrylic pressure sensitive adhesive silicone pressure sensitive adhesive backing film 15 cm square release liner 30.375 cm square poly(butyl methacrylate-co-methyl methacrylate) - treatment of patients with: · mild to moderately severe dementia of the alzheimer's type (also termed probable alzheimer's disease or alzheimer's disease) · severe dementia of the alzheimer's type.
exelon patch 20
novartis new zealand ltd - rivastigmine 36mg; ; - transdermal patch - 17.4 mg/24h - active: rivastigmine 36mg excipient: dimeticone dl-alpha tocopherol acrylic pressure sensitive adhesive silicone pressure sensitive adhesive backing film 20 cm square release liner 40.5 cm square poly(butyl methacrylate-co-methyl methacrylate) - treatment of patients with: · mild to moderately severe dementia of the alzheimer's type (also termed probable alzheimer's disease or alzheimer's disease) · severe dementia of the alzheimer's type.
exelon patch 5
novartis new zealand ltd - rivastigmine 9mg; ; - transdermal patch - 4.6 mg/24h - active: rivastigmine 9mg excipient: dimeticone dl-alpha tocopherol acrylic pressure sensitive adhesive silicone pressure sensitive adhesive backing film 5 cm square release liner 10.125 cm square poly(butyl methacrylate-co-methyl methacrylate) - treatment of patients with: · mild to moderately severe dementia of the alzheimer's type (also termed probable alzheimer's disease or alzheimer's disease) · severe dementia of the alzheimer's type.
nicorette
johnson & johnson (new zealand) limited - nicotine 8.3mg (10cm² patch delivers 5mg/16hours.); - transdermal patch - 5mg/16hours - active: nicotine 8.3mg (10cm² patch delivers 5mg/16hours.)
nicotrol
johnson & johnson (new zealand) limited - nicotine 8.3mg (as a 10cm² patch delivering 5mg/16hours); - transdermal patch - 0.31 mg/h - active: nicotine 8.3mg (as a 10cm² patch delivering 5mg/16hours)